Free Trial

Inhibrx (INBX) News Today

Inhibrx logo
$12.14 -0.01 (-0.04%)
As of 01:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Inhibrx, Inc. stock logo
Boothbay Fund Management LLC Takes Position in Inhibrx, Inc. (NASDAQ:INBX)
Boothbay Fund Management LLC acquired a new position in Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 28,230 shares of the company's stock, valued at approx
Inhibrx, Inc. stock logo
Marshall Wace LLP Takes $825,000 Position in Inhibrx, Inc. (NASDAQ:INBX)
Marshall Wace LLP acquired a new stake in Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 53,586 shares of the company's stock, valued at approximately $825,000. Marshall Wace LLP ow
Inhibrx, Inc. stock logo
Castalian Partners LLC Purchases Shares of 191,533 Inhibrx, Inc. (NASDAQ:INBX)
Castalian Partners LLC purchased a new stake in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 191,533 shares of the company's stock, valued a
Inhibrx, Inc. stock logo
Geode Capital Management LLC Invests $3.93 Million in Inhibrx, Inc. (NASDAQ:INBX)
Geode Capital Management LLC purchased a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 255,133 shares of the company's stock, valued at approximat
Inhibrx, Inc. stock logo
Birchview Capital LP Acquires Shares of 32,110 Inhibrx, Inc. (NASDAQ:INBX)
Birchview Capital LP purchased a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 32,110 shares of the company's stock, val
Inhibrx, Inc. stock logo
Credit Industriel ET Commercial Makes New $989,000 Investment in Inhibrx, Inc. (NASDAQ:INBX)
Credit Industriel ET Commercial purchased a new stake in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 64,217 shares of the company's stock, valued at approximately
Inhibrx, Inc. stock logo
Cigogne Management SA Purchases New Holdings in Inhibrx, Inc. (NASDAQ:INBX)
Cigogne Management SA acquired a new position in Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 75,932 shares of the company's stock, valued at approximate
Inhibrx, Inc. stock logo
54,345 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Russell Investments Group Ltd.
Russell Investments Group Ltd. bought a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 54,345 shares of the company's stock, val
Inhibrx, Inc. stock logo
Walleye Capital LLC Makes New $8.93 Million Investment in Inhibrx, Inc. (NASDAQ:INBX)
Walleye Capital LLC bought a new stake in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 579,999 shares of the company's stock, valued at approximately $8,932,000. Walleye Capital LLC o
Inhibrx, Inc. stock logo
Kennedy Capital Management LLC Takes $2.55 Million Position in Inhibrx, Inc. (NASDAQ:INBX)
Kennedy Capital Management LLC acquired a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 165,681 shares of the company's stock, valued at approximately $
Inhibrx, Inc. stock logo
Arbiter Partners Capital Management LLC Purchases Shares of 28,095 Inhibrx, Inc. (NASDAQ:INBX)
Arbiter Partners Capital Management LLC purchased a new stake in Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 28,095 shares of the company's stock, valued at approximately
Inhibrx, Inc. stock logo
36,195 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Yakira Capital Management Inc.
Yakira Capital Management Inc. bought a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 36,195 shares of the company's stock, valued a
Inhibrx, Inc. stock logo
Rangeley Capital LLC Takes $761,000 Position in Inhibrx, Inc. (NASDAQ:INBX)
Rangeley Capital LLC bought a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 49,401 shares of the company's stock, valued at approximately $
Inhibrx, Inc. stock logo
Slotnik Capital LLC Acquires New Holdings in Inhibrx, Inc. (NASDAQ:INBX)
Slotnik Capital LLC acquired a new position in Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 388,000 shares of the company's stock, valued at approximately
Inhibrx, Inc. stock logo
Charles Schwab Investment Management Inc. Invests $503,000 in Inhibrx, Inc. (NASDAQ:INBX)
Charles Schwab Investment Management Inc. acquired a new stake in Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 32,657 shares of the company's stock, valued at app
Inhibrx, Inc. stock logo
Short Interest in Inhibrx, Inc. (NASDAQ:INBX) Declines By 19.7%
Inhibrx, Inc. (NASDAQ:INBX - Get Free Report) saw a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 955,400 shares, a decrease of 19.7% from the February 28th total of 1,190,000 shares. Currently, 9.6% of the company's shares are short sold. Based on an average daily volume of 91,300 shares, the days-to-cover ratio is currently 10.5 days.
Inhibrx, Inc. stock logo
20,492 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Corient Private Wealth LLC
Corient Private Wealth LLC purchased a new stake in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 20,492 shares of the company's stock, valued at approximately
Inhibrx, Inc. stock logo
51,445 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Bank of New York Mellon Corp
Bank of New York Mellon Corp acquired a new stake in Inhibrx, Inc. (NASDAQ:INBX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 51,445 shares of the company's stock, val
Inhibrx, Inc. stock logo
Meridian Wealth Advisors LLC Buys New Shares in Inhibrx, Inc. (NASDAQ:INBX)
Meridian Wealth Advisors LLC bought a new stake in Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 25,000 shares of the company's stock, valued at approximately $385,000. Me
Inhibrx, Inc. stock logo
Inhibrx (NASDAQ:INBX) Releases Earnings Results, Misses Expectations By $0.21 EPS
Inhibrx (NASDAQ:INBX - Get Free Report) released its quarterly earnings results on Monday. The company reported ($3.09) earnings per share for the quarter, missing the consensus estimate of ($2.88) by ($0.21). The firm had revenue of $0.10 million during the quarter.
Inhibrx, Inc. stock logo
HighTower Advisors LLC Invests $12.04 Million in Inhibrx, Inc. (NASDAQ:INBX)
HighTower Advisors LLC bought a new position in Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 781,752 shares of the company's stock, valued at approximately $12,039,000. High
Inhibrx, Inc. stock logo
Inhibrx (INBX) to Release Quarterly Earnings on Thursday
Inhibrx (NASDAQ:INBX) will be releasing earnings before the market opens on Thursday, February 27, Financial Modeling Prep reports.
Inhibrx, Inc. stock logo
Inhibrx, Inc. (NASDAQ:INBX) Sees Significant Decline in Short Interest
Inhibrx, Inc. (NASDAQ:INBX - Get Free Report) was the recipient of a large drop in short interest in January. As of January 31st, there was short interest totalling 1,220,000 shares, a drop of 5.4% from the January 15th total of 1,290,000 shares. Based on an average daily trading volume, of 86,400 shares, the days-to-cover ratio is presently 14.1 days. Approximately 12.3% of the shares of the stock are sold short.
Inhibrx, Inc. stock logo
Inhibrx (INBX) Expected to Announce Earnings on Thursday
Inhibrx (NASDAQ:INBX) will be releasing earnings before the market opens on Thursday, February 13, Financial Modeling Prep reports.
Inhibrx, Inc. stock logo
JPMorgan Chase & Co. Sells 39,130 Shares of Inhibrx, Inc. (NASDAQ:INBX)
JPMorgan Chase & Co. trimmed its position in Inhibrx, Inc. (NASDAQ:INBX - Free Report) by 88.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,135 shares of the company's stock after selling 39,130 sha
Inhibrx, Inc. stock logo
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes $348,000 Position in Inhibrx, Inc. (NASDAQ:INBX)
Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in shares of Inhibrx, Inc. (NASDAQ:INBX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 22,584 sha
Inhibrx Biosciences Inc (INBX) Gets a Hold from JMP Securities
Inhibrx, Inc. stock logo
Inhibrx (NASDAQ:INBX) Receives "Market Perform" Rating from JMP Securities
JMP Securities reaffirmed a "market perform" rating on shares of Inhibrx in a report on Wednesday.
Inhibrx, Inc. stock logo
Inhibrx, Inc. (NASDAQ:INBX) Sees Large Increase in Short Interest
Inhibrx, Inc. (NASDAQ:INBX - Get Free Report) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 1,200,000 shares, a growth of 10.1% from the November 30th total of 1,090,000 shares. Currently, 12.1% of the company's stock are sold short. Based on an average daily trading volume, of 77,600 shares, the short-interest ratio is presently 15.5 days.
Inhibrx, Inc. stock logo
Inhibrx, Inc. (NASDAQ:INBX) Short Interest Up 5.8% in November
Inhibrx, Inc. (NASDAQ:INBX - Get Free Report) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 1,090,000 shares, a growth of 5.8% from the November 15th total of 1,030,000 shares. Based on an average daily volume of 84,700 shares, the days-to-cover ratio is presently 12.9 days. Currently, 11.0% of the company's stock are sold short.
Inhibrx, Inc. stock logo
Jon Faiz Kayyem Purchases 69,686 Shares of Inhibrx, Inc. (NASDAQ:INBX) Stock
Inhibrx, Inc. (NASDAQ:INBX - Get Free Report) Director Jon Faiz Kayyem bought 69,686 shares of Inhibrx stock in a transaction dated Tuesday, November 19th. The stock was purchased at an average price of $14.23 per share, with a total value of $991,631.78. Following the purchase, the director now owns 51,093 shares in the company, valued at approximately $727,053.39. This represents a -374.80 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Inhibrx Biosciences, Inc. (INBX)
Inhibrx, Inc. stock logo
Inhibrx, Inc. (NASDAQ:INBX) Short Interest Up 9.0% in October
Inhibrx, Inc. (NASDAQ:INBX - Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 976,700 shares, a growth of 9.0% from the October 15th total of 895,700 shares. Currently, 9.7% of the company's shares are short sold. Based on an average daily volume of 89,700 shares, the short-interest ratio is currently 10.9 days.
Stocks Close Lower on Hawkish Powell
Inhibrx Biosciences Inc (INBX)
Get Inhibrx News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter.

INBX Media Mentions By Week

INBX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INBX
News Sentiment

1.63

0.72

Average
Medical
News Sentiment

INBX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INBX Articles
This Week

5

1

INBX Articles
Average Week

Get Inhibrx News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INBX) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners